Evotec ESG Presentation Deck

evotec 23% / 30% (CEO / CXO) Non-performance based remuneration Base salary & fringe benefits¹) Paid annually PAGE 24 More than 2/3 at risk New remuneration framework 14% / 11% (CEO / CXO) 77% (CEO) / 70% (CxO) of Total Remuneration at risk Upfront STI²) (bonus) 20% / 17% (CEO / CXO) Performance based remuneration Deferred ST12) (awarded in company shares) Vesting period of 4 years 1) Benefits Value €110k CEO / €70k CxO 2) CEO: 40% Upfront STI /60% Deferred STI 43% / 42% (CEO / CXO) Long-term-share-based remuneration (share performance plan)

View entire presentation